Venaxis Inc news

   Watch this stock
Showing stories 1 - 10 of about 21   

Articles published

APPY 1.66 -0.01 (-0.60%)
price chart
Venaxis to Present at September Investor Conferences
CASTLE ROCK, Colo., Aug. 28, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1� Test, a rapid blood test for aiding in identifying children ...
Related articles »  
Today's Hot List: Sevcon, Inc. (NASDAQ:SEV), SanDisk Corp. (NASDAQ:SNDK ...
Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1(TM) Test, a rapid, multi-analyte assay for aiding in identifying children, adolescent and young adult patients that ...
Eye Catching Stocks: Hertz Global (NYSE:HTZ), BlackBerry (NASDAQ:BBRY ...
Hertz Global Holdings Inc. (NYSE:HTZ) reached an agreement in principle with billionaire investor Carl Icahn to appoint three directors to the board of the rental- car company in place of current members.
Investors Watch List: AbbVie Inc. (NYSE:ABBV), CEMEX, S.A.B. de C.V. (NYSE ...
Venaxis, Inc. (NASDAQ:APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1� Test, a rapid blood test for aiding in identifying children, adolescent, and young adult patients in the ...
Morning Buzz: OXiGENE (NASDAQ:OXGN), Pluristem Therapeutics (NASDAQ ...
On 28 AUG Venaxis, Inc. (NASDAQ:APPY) announced it will present at three upcoming investor conferences: the Rodman & Renshaw 16(th) Annual Global Investment Conference being held in New York on September 8-10, 2014, the Aegis Capital 2014 ...
Why Need to Watch: Cavium (NASDAQ:CAVM), Amgen (NASDAQ:AMGN ...
Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid blood test for aiding in identifying children, adolescent, and young adult patients in the ...
Related articles »  
Point of Care Diagnostic Testing World Markets
15.29 Integrity Applications 493 15.30 MBio Diagnostics, Inc. 493 15.31 Menssana Research, Inc. 493 15.32 Metaara Medical Technologies, Inc. 494 15.33 QuantuMDx Group 494 15.34 Venaxis, Inc. 494 15.35 Vivacta Limited 494 15.36 Wave 80 Biosciences ...
Related articles »  
Venaxis closes public offering of common shares
Venaxis prices $20 mln public offering of common shares